Diagnostic and therapeutic value of carbohydrate antigen 199 in digestive system diseases

doi:10.3877/cma.j.issn.1674-0785.2017.18.008

Abstract

Abstract:

Carbohydrate antigen 199 (CA199) is a high-molecular-weight glycoprotein that is mainly distributed in the fetal pancreas, gallbladder, liver, and intestine. Circulating blood CA199 level is low in healthy adults, but it is significantly higher in patients with malignant tumors of the digestive tract. Therefore, it is widely used as an important clinical indicator in the diagnosis or prognosis evaluation of these diseases. However, recent studies have shown that CA199 also increases in some gastrointestinal benign diseases such as gallstones, pancreatitis, and benign liver diseases. In this paper, we review the expression of CA199 in different digestive system diseases and the related clinical significance.

Key words: Carbohydrate antigen 199, Digestive system diseases, Malignant neoplasms, Benign disease, Diagnosis and treatment

Dongling Teng, Guotao Lu, Dan Wang, Tianyu Hou, Weiming Xiao. Diagnostic and therapeutic value of carbohydrate antigen 199 in digestive system diseases[J]. Chinese Journal of Clinicians(Electronic Edition), 2017, 11(18): 2245-2248.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhlcyszz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0785.2017.18.008

https://zhlcyszz.cma-cmc.com.cn/EN/Y2017/V11/I18/2245

References 42

[1]	Chen Y, Gao SG, Chen JM, et al. Serum CA242, CA199, CAl25, CEA, and TSGF aye biomaykers for the efficacy and prognosis of cryoa-blation in pancreatic cancer patients [J]. J Cell Biochem Biophys. 2015, 71(3): 1287-1291.
[2]	丁磊, 王海刚, 钱铮, 等. 3464例临床血清CA199异常增高分析 [J]. 中国伤残医学, 2015, 23(22): 192-194.
[3]	孟祥鹏, 王宝胜, 刘臻, 等. SDF-1与CA199在胰腺癌中的表达及临床意义 [J]. 现代肿瘤医学, 2014, 22(1): 131-133.
[4]	Aldakkak M, Christians KK, Krepline AN, et al. Pre-treatment carbohydrate antigen 19-9 does not predict the response to neoadjuvant therapy in patients with localized pancreatic cancer [J]. HPB (Oxford), 2015, 17(10): 942-952.
[5]	Kuisma M, Karppinen J, Niinimäki J, et al. Modic changes in endplates of lumbar vertebral bodies: prevalence and association with low back and sciatic pain among middle-aged male workers [J]. Spine(Phila Pa 1976). 2007, 32(10): 1116-1122.
[6]	颜海希, 郑静, 金霞霞, 等. 联合检测CA199、CA242、CEA对胰腺癌诊断价值的Meta分析 [J]. 肿瘤学杂志, 2013, 19(7): 532-538.
[7]	李文兵, 高波. 联合检测肿瘤标志物在消化系恶性肿瘤中的应用研究 [J]. 现代中西医结合杂志, 2014, 23(18): 1954-1956.
[8]	杨会生, 王韩, 汤宛莹, 等. 联合检测CA724、CA199、CEA对胃癌诊断价值的Meta分析 [J]. 肿瘤学杂志, 2015, 21(9): 714-720.
[9]	刘群, 张浩, 周亚军. CA199、CA125、CEA检测对不同分期胰腺癌、胃癌诊断价值比较 [J]. 医学信息, 2013(18): 600-600.
[10]	Liu X, Cai H, Wang Y. Prognostic significance of tumour markers in Chinese patients with gastric cancer [J]. Anz Journal of Surgery, 2014, 84(6): 448-453.
[11]	Ychou M, Duffour J, Kramar A, et al. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer. [J]. Disease Markers, 2000, 16(3-4): 105-110.
[12]	He B, Zhang H Q, Xiong S P, et al. Changing patterns of Serum CEA and CA199 for Evaluating the Response to First-line Chemotherapy in Patients with Advanced Gastric Adenocarcinoma. [J]. Asian Pacific Journal of Cancer Prevention Apjcp, 2015, 16(8): 3111-3116.
[13]	Lindsey A, Freddie Bray, Rebecca L, et al. Global Cancer Statistics, 2012 [J]. CA CANCER J CLIN 2015; 00: 00-00.
[14]	李晓红, 杨丽, 李婉澜, 等. CA50及CA199在结肠癌患者中的临床应用价值 [J]. 检验医学与临床, 2015(21): 3248-3250.
[15]	陈蕾, 姜北海, 邸佳柏, 等. CA199在判断CEA正常的中晚期结直肠癌患者预后中的价值 [J]. 中国肿瘤临床, 2015, 42(15): 743-750.
[16]	Li A, Tan Z, Fu C, et al. Analysis of risk factors for bone metastasis after radical resection of colorectal cancer within 5 years [J]. Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Jan 25; 20(1): 58-61.
[17]	沈世强. 胆囊癌早期诊断的实验研究现状及展望 [J]. 中华实验外科杂志, 2010, 27(7): 853-854.
[18]	张航宇, 窦科峰. 超声联合肿瘤标志物CA19-9及超敏C反应蛋白检测对胆囊癌早期诊断准确性的影响 [J]. 解放军医学杂志, 2014, 39(3): 222-225.
[19]	张永东. 血清CA199、CA242、CA125联合检测对胆囊癌患者诊断的临床价值研究 [J]. 肝胆外科杂志, 2016, 24(2): 106-110.
[20]	Liu Y, Sun J, Zhang Q, et al. Identification of bile survivin and carbohydrate antigen 199 in distinguishing cholangiocarcinoma from benign obstructive jaundice [J]. Biomarkers in Medicine, 2017.
[21]	Jo J H, Chung M J, Park J Y, et al. High serum CA19-9 levels are associated with an increased risk of cholangiocarcinoma in patients with intrahepatic duct stones: a case-control study. [J]. Surgical Endoscopy, 2013, 27(11): 4210.
[22]	胡刚, 湛汇, 胡如进. 肝内胆管结石合并肝内胆管癌发病危险因素及预测指标分析 [J]. 胃肠病学和肝病学杂志, 2015, 24(6): 742-744.
[23]	支杰华, 高雪峰, 许松欣, 等. 小肠炎性纤维息肉导致CA199升高一例 [J]. 中华消化内镜杂志, 2016, 33(11): 806-807.
[24]	Zhou JP, Dong M, Zhang Y, et al. Giant mucinous biliary cystadenoma: a case report [J]. Hepatobiliary Pancreat Dis Int, 2007, 6(1): 101-103.
[25]	方恒忠, 陈炯, 赵金钱, 等. 血清学肿瘤标志物与胰腺癌诊断及分期的关系 [J]. 国际外科学杂志, 2016, 43(3): 171-173.
[26]	刘梦奇, 郭文治, 张水军. 癌抗原199在肝脏疾病中的基础研究进展 [J]. 中华实验外科杂志, 2016, 33(10): 2432-2434.
[27]	王淑君, 阮戈冲, 柏小寅, 等. 以急性胰腺炎为首发临床表现的胰腺癌1例 [J]. 胃肠病学和肝病学杂志, 2015, 24(10): 1281-1282.
[28]	Mujica VR, Barkin JS, Go VLW. Acute pancreatitis secondary to pancreatic carcinoma [J]. Pancreas 2000; 21: 329-32.
[29]	Chung SD, Chen KY, Xirasagar S, et al. More than 9-times increased risk for pancreatic cancer among patients with acute pancreatitis in Chinese population [J]. Pancreas, 2012, 41(1): 142-146.
[30]	张玮玮. 血清CA199检测在梗阻性黄疸中的诊断价值 [J]. 山西医药杂志, 2014(16): 1975-1977.
[31]	Ramsey ML, Conwell D L, Hart PA. Complications of Chronic Pancreatitis [J]. Dig Dis Sci, 2017, 62(7): 1745-1750.
[32]	李明欣, 尚东, 徐贺, 等. 首发症状为急慢性胰腺炎的胰腺癌诊断与治疗 [J]. 中华消化外科杂志, 2014, 13(11): 859-863.
[33]	Mayerle J, Kalthoff H, Reszka R, et al. Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis [J]. Gut, 2017, 67(1): 128-137.
[34]	Kaur S, Smith L M, Patel A, et al. A Combination of MUC5AC and CA19-9 Improves the Diagnosis of Pancreatic Cancer: A Multicenter Study [J]. Am J Gastroenterol, 2017, 112(1): 172-183.
[35]	鲁琼, 贺铮雯, 张乐之, 等. 血清IgG4和CA199联合检测在自身免疫性胰腺炎和胰腺癌鉴别诊断中的意义 [J]. 检验医学, 2011, 26(11): 746-749.
[36]	Heerde M J V, Buijs J, Hansen B E, et al. Serum Level of Ca 19-9 Increases Ability of IgG4 Test to Distinguish Patients with Autoimmune Pancreatitis from Those with Pancreatic Carcinoma [J]. Dig Dis Sci, 2014, 59(6): 1322-1329.
[37]	董文志, 莫小华. 血清CA199在肝内外胆管结石表达的相关性研究[J/CD]. 世界最新医学信息文摘（电子版）, 2015, 26(11).
[38]	徐惠明, 周静. 血清CA199、胆系酶、胆红素在不同胆系良性疾病中的水平研究 [J]. 实用临床医药杂志, 2016, 20(11): 183-184.
[39]	熊会玲, 范彦, 胡美, 等. 血清CA199对良恶性胆道疾病的意义 [J]. 临床消化病杂志, 2013, 25(6): 327-329.
[40]	王丽. 肝硬化Child-Pugh评分与血清CA125、CA199水平的关系 [J]. 胃肠病学和肝病学杂志, 2015, 24(2): 210-212.
[41]	崔春吉. 血清CA199检测在肝硬化中的临床价值 [J]. 临床消化病杂志, 2016, 28(2): 79-80.
[42]	严宪才, 缪英年, 吴志光, 等. 肝硬化患者血清CA199水平升高的原因及临床意义 [J]. 广东医学, 2008, 29(12): 2071-2073.

Please choose a citation manager

Content to export